Today: 10 June 2026
GE Vernova stock nudges up after Jefferies lifts target to $865, with earnings next
15 January 2026
2 mins read

GE Vernova stock nudges up after Jefferies lifts target to $865, with earnings next

New York, January 15, 2026, 12:58 (ET) — Regular session

  • Shares of GE Vernova climbed midday after Jefferies raised its price target and kept a Buy rating.
  • Investors are gearing up ahead of the company’s quarterly report and guidance update set for Jan. 28
  • The big question is whether orders and cash flow can keep up with the soaring power demand driven by data centers

Shares of GE Vernova climbed $4.85, or roughly 0.8%, to $649.03 in midday trading Thursday in New York, following Jefferies’ decision to lift its price target from $830 to $865 while keeping a buy rating, MT Newswires reported. The stock hit an intraday high of $666 and a low of $647.92.

The new target arrives just under two weeks before GE Vernova releases its fourth-quarter and full-year results on Jan. 28, before the market opens. Traders are moving fast to jump on—or steer clear of—any momentum building ahead of that announcement.

The key question is whether GE Vernova can deliver on high expectations with solid results and a clear forecast. The company’s growth hinges on demand for grid equipment and gas turbines, a narrative that has attracted broad investor interest — but that enthusiasm can evaporate just as quickly.

Back in December, the company projected 2026 revenue between $41 billion and $42 billion, with free cash flow — the money left after expenses and capital spending — expected to hit $4.5 billion to $5.0 billion. It also raised its share buyback plan by $4 billion, Reuters reported. The outlet added that surging electricity demand from AI and cryptocurrency data centers is driving higher sales of turbines and grid equipment.

Some analysts see more upside than the market currently prices in. After a December investor day, RBC Capital said, “The outlook leaves room for further outperformance.” Meanwhile, William Blair’s Jed Dorsheimer noted turbine production slots are booked through 2028, per Reuters. The report also highlighted Siemens Energy and Mitsubishi Heavy Industries raising their targets, underscoring how this cycle remains global and fiercely competitive. Reuters

GE Vernova’s shares have bounced between roughly $617 and $666 throughout this month, reflecting investors’ shifting expectations after a strong rally late last year.

Jefferies’ update piles onto a string of target revisions spurred by the company’s positive long-range outlook back in December. Here, the price targets act less as precise predictions and more as a gauge of how much optimism analysts believe is baked into the stock.

The setup cuts both ways. Shares already price in a solid 2026, so any slowdown in orders, margin pressure, or weaker demand for power equipment could weigh heavily on the stock. Supply-chain issues remain a real threat: CEO Scott Strazik flagged concerns about yttrium availability back in December, citing China’s export restrictions and saying, “We are very focused on it every day.” Reuters

Jan. 28 is the next key date. Investors expect updates on the order book, cash flow, and any revisions to the 2026 outlook. They’ll also watch for details on how quickly the company intends to convert its buyback authorization into actual stock repurchases.

Stock Market Today

  • MindWalk Launches ReefIQ for Enhanced AI-Driven Drug Discovery
    June 10, 2026, 9:49 AM EDT. MindWalk Holdings Corp. (NASDAQ: HYFT) introduced ReefIQ™, a biological context layer designed to unify fragmented drug discovery data for AI analysis. The technology integrates diverse biological information such as sequences, structures, and assay results into a governed, queryable network. This enables MindWalk's LensAI tool and client-selected models to perform more accurate hypothesis generation and target discovery. By preserving data provenance and program history, ReefIQ aims to enhance trust and efficiency in regulated drug development environments. CEO Dr. Jennifer Bath emphasized that ReefIQ closes the data gaps in biological context, crucial for reliable AI-driven insights in life sciences.

Latest articles

Rigetti Computing Stock Falls as Sale Notice Tests $100 Million Quantum Rally

Rigetti Computing Stock Falls as Sale Notice Tests $100 Million Quantum Rally

10 June 2026
Rigetti Computing plunged 9.55% to $19.69 Tuesday and dipped further premarket after director Ray O. Johnson filed to sell 122,188 shares worth $2.6 million, testing investor confidence following a recent rally on news of a potential $100 million U.S. Commerce Department quantum-computing award, with traders watching for binding funding terms amid ongoing volatility.
PATH slips again, investors keep questioning AI automation bet

PATH slips again, investors keep questioning AI automation bet

10 June 2026
UiPath shares slid 3.76% to $10.75 and dropped another 1.49% pre-market as investors focused on slowing annual recurring revenue growth—up 12% to $1.901 billion versus 17% revenue growth—raising doubts about AI automation’s impact on recurring sales; second-quarter ARR guidance of $1.929–$1.934 billion is now the key number for PATH’s stock direction.
POET Technologies stock climbs before the bell as call-option volume spikes
Previous Story

POET Technologies stock climbs before the bell as call-option volume spikes

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead
Next Story

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead

Go toTop